Farah F Salahuddin, MD
Rheumatology · Watsonville
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 4
Offices
4 locations · Livwell Health LLC · Ukiah Adventist Hospital
Hospitals listed: Adventist Health Ukiah Valley · Dominican Hospital · Memorial Hospital Los Banos · Natividad Medical Center · Watsonville Community Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Salahuddin’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A119821 · Current
Licensed to practise in California · since 2012 · expires 2027-07-31 · Aga Khan University, Aga Khan Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
5 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Adventist Health Ukiah ValleyUkiah, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 3 of 5 · 66% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Rate of emergency department (ED) visits for patients receiving outpatient chemotherapy: 7.9 (5.8 to 10.5) · 253 cases, Jan 2024 – Dec 2024
- Dominican HospitalSanta Cruz, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 4 of 5 · 68% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Postoperative sepsis rate: 11.66 (8.02 to 15.3) · 412 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.168, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.169, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.489, Oct 2024 – Sep 2025
- Memorial Hospital Los BanosLos Banos, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 59% would definitely recommend itOverall rating: 3 of 5 starsNo measure marked better or worse than the national rate
- Natividad Medical CenterSalinas, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Natividad Medical CenterPatients rate it 3 of 5 · 71% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.316, Oct 2024 – Sep 2025
- Watsonville Community HospitalWatsonville, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPatients rate it 3 of 5 · 66% would definitely recommend itOverall rating: 2 of 5 starsNo measure marked better or worse than the national rate
See every measure and the patient survey for Adventist Health Ukiah Valley
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 4 the same, 0 worse of 4 measures. Readmissions: 0 better, 8 the same, 0 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 7.9 (5.8 to 10.5) · 253 cases | Worse | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.92 (0 to 1.95) · 319 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.92 (0.51 to 1.32) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.3 · 38 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.9 · 137 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.4 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.3 · 74 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 647 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 2,093 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.29 (0.08 to 0.51) · 2,081 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.64 (2.23 to 7.05) · 328 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 99 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.45 (0.79 to 4.11) · 309 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.96 (0 to 15.74) · 117 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.32 (2.24 to 10.4) · 103 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.18 to 3.17) · 119 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.29 (0 to 1.2) · 1,614 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.891 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.607 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.396 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 114 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -0.9 · 171 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 6.5 · 270 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 234 cases | None | Jul 2023 – Jun 2025 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.4 (8 to 13.6) · 253 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 37 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.5 (10.4 to 17.4) · 1,320 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.4) · 361 cases | No different | Jan 2024 – Dec 2024 |
What patients said (341 patients answered, 15% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 62% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 33% |
| "YES", patients would definitely recommend the hospital | 66% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Dominican Hospital
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 1 better, 8 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Postoperative sepsis rateComplications and deaths | 11.66 (8.02 to 15.3) · 412 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.168 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.169 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.489 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.01 (0.06 to 1.95) · 1,248 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.14 (0.85 to 1.43) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 134.37 (94.33 to 174.41) · 132 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 54 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.2 · 137 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12 · 228 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.5 · 534 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.8 · 491 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 278 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 2,973 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.14 (0 to 0.34) · 7,510 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,695 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.42 (1.44 to 5.4) · 1,594 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.26 (0 to 2.76) · 436 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.85 (0.4 to 3.29) · 1,474 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.73 (3 to 14.46) · 437 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.58 (0.13 to 3.03) · 343 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.57 (0 to 1.17) · 6,336 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.615 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.937 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 212 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 505 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 45 · 237 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.5 · 594 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.9 · 510 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.9 · 473 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.4 to 7.8) · 126 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13 (9.4 to 17.7) · 126 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 12.7 · 43 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 143 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.1 (9.4 to 15.4) · 1,585 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 390 cases | No different | Jan 2024 – Dec 2024 |
What patients said (774 patients answered, 23% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 4 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 77% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 32% |
| "YES", patients would definitely recommend the hospital | 68% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Memorial Hospital Los Banos
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 3 the same, 0 worse of 3 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.04 (0 to 2.13) · 48 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.94 (0.46 to 1.43) | No different | Jul 2022 – Jun 2024 |
| Death rate for heart failure patientsComplications and deaths | 14.5 · 47 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.4 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.5 · 33 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.6 · 324 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.44) · 797 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.05 to 0.48) · 753 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.36 (0.77 to 5.95) · 105 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.31 (0.58 to 4.03) · 100 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.76 (0.23 to 3.29) · 31 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.49 (0 to 1.69) · 573 cases | No different | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.9 · 56 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 20.3 · 47 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 34.5 · 80 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18 · 86 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.5 (9.8 to 18.5) · 59 cases | No different | Jan 2022 – Dec 2024 |
What patients said (172 patients answered, 12% of those asked)
| Cleanliness | 5 |
| Nurse communication | 4 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 81% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 64% |
| Yes, staff "did" give patients this information | 80% |
| Yes, staff "did" give patients information about help after discharge | 75% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 81% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 82% |
| Nurses "always" explained things so they could understand | 78% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 48% |
| "YES", patients would definitely recommend the hospital | 59% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Natividad Medical Center
Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 6 the same, 0 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.316 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.98 (0 to 2.04) · 332 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.18 (0.76 to 1.6) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 165.77 (109.76 to 221.78) · 28 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 9.9 · 47 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 80 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 18.4 · 110 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.5 · 34 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.4 · 609 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.03 to 0.48) · 2,445 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 2,213 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.36 (2.03 to 6.7) · 564 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.36) · 79 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.08 (0.44 to 3.71) · 555 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.67 (1.19 to 20.15) · 87 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.92 (0.71 to 9.12) · 79 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.73 (0.21 to 3.24) · 81 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.07 (0.12 to 2.02) · 1,742 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.462 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.9 · 62 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8.4 · 93 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -7.3 · 121 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 100 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 32 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.9) · 162 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.7 to 1.5) · 72 cases | No different | Jan 2024 – Dec 2024 |
What patients said (966 patients answered, 55% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 37% |
| "YES", patients would definitely recommend the hospital | 71% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Watsonville Community Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 4 the same, 2 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.01 (0 to 2.08) · 194 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.88 (0.44 to 1.32) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.3 · 27 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 13.6 · 98 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.7 · 210 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.5 · 74 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 604 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.03 to 0.49) · 1,963 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.04 to 0.47) · 1,942 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.15 (0.64 to 5.66) · 232 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.66 (0 to 3.39) · 33 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.24 (0.54 to 3.95) · 216 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.86 (0 to 18.76) · 37 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.09 (0.81 to 9.36) · 32 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.73 (0.21 to 3.24) · 71 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.35 (0 to 1.35) · 1,464 cases | No different | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.351 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.9 · 82 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 52.2 · 119 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 31.4 · 221 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 182 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 28 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (9.5 to 17.2) · 311 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.5) · 46 cases | No different | Jan 2024 – Dec 2024 |
What patients said (264 patients answered, 12% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 3 |
| Room was "always" clean | 77% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 66% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 79% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 66% |
| Staff "always" explained possible side effects | 53% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$125,101
Medicare paid this office $125,101 for 361 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Injection, denosumab, 1 mg | 16 | $20,073 | None |
| Long return visit (40+ min) | 83 | $18,747 | $141 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 64 | $9,125 | $140 |
| Return visit (30+ min) | 59 | $8,136 | $116 |
| New patient visit (60+ min) | 37 | $7,259 | $191 |
See all 17 services
| Injection, denosumab, 1 mg | 16 | $20,073 | None |
| Long return visit (40+ min) | 83 | $18,747 | $141 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 64 | $9,125 | $140 |
| Return visit (30+ min) | 59 | $8,136 | $116 |
| New patient visit (60+ min) | 37 | $7,259 | $191 |
| New patient visit (45+ min) | 35 | $5,162 | $147 |
| Short return visit (20+ min) | 51 | $5,001 | $88 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 21 | $3,856 | $101 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 139 | $3,133 | $14 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 25 | $2,162 | $66 |
| New patient visit (30+ min) | 13 | $1,407 | $108 |
| Aspiration and/or injection of fluid from large joint | 17 | $1,131 | $60 |
| Long return visit (40+ min) | 14 | $958 | $68 |
| Principal care management services for a single high-risk disease, first 30 minutes provided personally by qualified health care professional, per calendar month. | 13 | $836 | $60 |
| Injection of drug or substance under skin or into muscle | 26 | $718 | $15 |
| Short return visit | 11 | $655 | $60 |
| Injection, methylprednisolone acetate, 1 mg | 13 | $62 | None |
Who their Medicare patients are
361 Original Medicare patients in 2024. Average age 75 · Under 65 11% · 85 and older 16% · Women 68% · Also on Medicaid 32% · Health risk score 1.69. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Diabetes 32% · Coronary heart disease 26% · Chronic kidney disease 26% · Atrial fibrillation 25% · Heart failure 24% · Depression 24% · COPD 19% · Cancer 18% · Dementia 13% · Stroke 11%.
The office billed $578,693, Medicare allowed $161,618 and paid $125,101; for 6,226 services of 34 kinds; $51,134 of it was for drugs given in the office and $73,967 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 361 | 6,226 | 75 | 1.69 | $578,693 | $125,101 |
| 2023 | 402 | 787 | 73 | 1.86 | $530,996 | $79,839 |
| 2022 | 208 | 321 | 73 | 2.06 | $125,335 | $34,905 |
| 2021 | 187 | 6,957 | 73 | 1.28 | $275,386 | $111,102 |
| 2020 | 285 | 27,188 | 73 | 1.31 | $761,921 | $317,077 |
| 2019 | 124 | 2,537 | 70 | 1.18 | $68,042 | $21,662 |
| 2017 | 20 | 8,028 | 73 | 2.25 | $128,385 | $28,994 |
| 2016 | 63 | 105 | 77 | 1.87 | $20,989 | $9,633 |
| 2013 | 129 | 341 | 70 | 3.78 | $62,920 | $30,672 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 115 | $16,682 | $143 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 89 | $14,315 | $65 |
| Long return visit (40+ min) | 50 | $11,373 | $131 |
| Hospital discharge day management, more than 30 minutes | 69 | $6,612 | $96 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 40 | $6,610 | $99 |
| New patient visit (60+ min) | 51 | $6,348 | $124 |
| New patient visit (60+ min) | 21 | $3,848 | $183 |
| Long return visit (40+ min) | 30 | $3,812 | $106 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 28 | $3,009 | $107 |
| Return visit (30+ min) | 13 | $1,423 | $95 |
| New patient visit (45+ min) | 11 | $1,083 | $98 |
| Hospital discharge day management, 30 minutes or less | 11 | $678 | $62 |
2022: 9 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 62 | $10,318 | $166 |
| New patient visit (60+ min) | 40 | $5,174 | $129 |
| Long return visit (40+ min) | 22 | $2,933 | $105 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 22 | $2,653 | $60 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $2,078 | $87 |
| New patient visit (60+ min) | 11 | $1,816 | $165 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,702 | $113 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 20 | $1,686 | $80 |
| New patient visit (45+ min) | 11 | $1,114 | $101 |
2021: 6 services
| Return visit (30+ min) | 139 | $17,335 | $95 |
| Long return visit (40+ min) | 42 | $6,901 | $144 |
| New patient visit (60+ min) | 14 | $2,636 | $188 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 12 | $1,200 | $86 |
| Injection of drug or substance under skin or into muscle | 28 | $673 | $13 |
| Injection, methylprednisolone acetate, 40 mg | 16 | $74 | None |
2020: 11 services
| Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 13 | $115,566 | None |
| Injection, romosozumab-aqqg, 1 mg | 11 | $53,037 | None |
| Return visit (30+ min) | 231 | $45,689 | $88 |
| New patient visit (45+ min) | 80 | $10,782 | $135 |
| Long return visit (40+ min) | 18 | $2,551 | $128 |
| Injection of drug or substance under skin or into muscle | 34 | $2,207 | $13 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 22 | $2,174 | $75 |
| Short return visit (20+ min) | 27 | $1,749 | $60 |
| Complete ultrasound scan of joint | 12 | $844 | $65 |
| Aspiration and/or injection of fluid from large joint | 13 | $832 | $46 |
| Injection, methylprednisolone acetate, 40 mg | 24 | $122 | None |
2019: 3 services
| Return visit (30+ min) | 98 | $9,706 | $91 |
| New patient visit (45+ min) | 12 | $1,672 | $139 |
| Short return visit (20+ min) | 13 | $829 | $64 |
2016: 4 services
| Return visit (30+ min) | 23 | $3,413 | $100 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,389 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,157 | $64 |
| Short return visit (20+ min) | 13 | $957 | $68 |
2013: 5 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 66 | $11,216 | $163 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 35 | $8,014 | $84 |
| Hospital discharge day management, 30 minutes or less | 71 | $4,214 | $58 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 39 | $3,524 | $59 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $1,756 | $110 |
Medicaid work
$22,864 in 2024
Medicaid paid $22,864 for 153 billed services this clinician did in 2024, up to 21 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Long return visit (40+ min) | 110 | $21,671 |
| Prolonged outpatient evaluation and management service(s) time with or without direct patient contact beyond the required time of the primary service when the primary service level has been selected using total time, each 15 minutes of total time (List separately in addition to the code of the outpatient Evaluation and Management service) | 28 | $903 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 15 | $290 |
| 2024 | 153 | 3 | 21 | $22,864 |
| 2023 | 397 | 11 | 21 | $10,623 |
| 2022 | 841 | 13 | 31 | $17,847 |
| 2021 | 101 | 1 | 27 | $8,583 |
| 2020 | 83 | 1 | 17 | $6,337 |
See the largest Medicaid services in earlier years
2023
| Long return visit (40+ min) | 17 | $2,355 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 152 | $2,306 |
| New patient visit (60+ min) | 12 | $2,223 |
| Clinic visit/encounter, all-inclusive | 14 | $2,041 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 45 | $1,250 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 35 | $449 |
| TOBACCO NON-USER | 12 | $0 |
| WEIGHT RECORDED | 28 | $0 |
| BODY MASS INDEX DOCD | 28 | $0 |
| Most recent systolic blood pressure < 140 mmhg | 26 | $0 |
| Most recent diastolic blood pressure < 90 mmhg | 28 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 91 | $13,071 |
| New patient visit (60+ min) | 61 | $2,189 |
| 1ST HOSP IP/OBS HIGH 75 | 14 | $2,115 |
| New patient visit (45+ min) | 13 | $338 |
| Telehealth transmission, per minute, professional services bill separately | 61 | $134 |
| TOBACCO NON-USER | 83 | $0 |
| WEIGHT RECORDED | 111 | $0 |
| BODY MASS INDEX DOCD | 111 | $0 |
| MOST RECENT LDL-C <100 MG/DL | 26 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 59 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 12 | $0 |
| Most recent systolic blood pressure < 140 mmhg | 97 | $0 |
2021
| Return visit (30+ min) | 101 | $8,583 |
2020
| Return visit (30+ min) | 83 | $6,337 |
Drugs they prescribed that Part D paid
$717,124
Pharmacies billed $717,124 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 4% of their Part D prescriptions (34 of 952) in 2024. Above the middle of the specialty; the typical internal medicine clinician is at 1%.
766 generic and fewer than 11 brand-name prescriptions · $717,124 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Humira(Cf) | 33 | $220,591 | $6,685 |
| Rinvoq | 18 | $157,411 | $8,745 |
| Methotrexate | 145 | $3,732 | $26 |
| Hydroxychloroquine Sulfate | 58 | $3,121 | $54 |
| Celecoxib | 32 | $1,938 | $61 |
See all 20 drugs
| Humira(Cf) | 33 | $220,591 | $6,685 |
| Rinvoq | 18 | $157,411 | $8,745 |
| Methotrexate | 145 | $3,732 | $26 |
| Hydroxychloroquine Sulfate | 58 | $3,121 | $54 |
| Celecoxib | 32 | $1,938 | $61 |
| Leflunomide | 40 | $1,795 | $45 |
| Colchicine | 14 | $1,132 | $81 |
| Sulfasalazine | 36 | $584 | $16 |
| Prednisone | 104 | $549 | $5 |
| Diclofenac | 15 | $400 | $27 |
| Mycophenolate Mofetil | 12 | $323 | $27 |
| Levothyroxine | 15 | $212 | $14 |
| Alendronate | 33 | $212 | $6 |
| Amitriptyline | 14 | $164 | $12 |
| Duloxetine | 15 | $155 | $10 |
| Amlodipine Besylate | 18 | $135 | $8 |
| Gabapentin | 14 | $112 | $8 |
| Allopurinol | 18 | $112 | $6 |
| Meloxicam | 22 | $85 | $4 |
| Tramadol | 23 | $82 | $4 |
Year by year
| 2024 | 952 | 270 | 4% (34) | None | $717,124 |
| 2023 | 698 | 195 | 4% (28) | 17% | $689,150 |
| 2022 | 310 | 98 | None | None | $224,051 |
| 2021 | 208 | 93 | 0% (0) | None | $7,624 |
| 2020 | 517 | 192 | None | None | $46,394 |
| 2019 | 1,153 | 279 | None | 39% | $648,391 |
| 2018 | 974 | 229 | None | None | $548,070 |
| 2017 | 616 | 164 | None | None | $241,974 |
| 2016 | 278 | 73 | None | None | $58,862 |
| 2015 | 65 | 25 | None | 17% | $5,508 |
| 2014 | 44 | 11 | 0% (0) | None | $2,096 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 15 drugs
| Humira(Cf) | 28 | $230,666 | $8,238 |
| Rinvoq | 24 | $159,094 | $6,629 |
| Methotrexate | 132 | $5,029 | $38 |
| Hydroxychloroquine Sulfate | 42 | $3,995 | $95 |
| Leflunomide | 29 | $1,717 | $59 |
| Mycophenolate Mofetil | 13 | $1,140 | $88 |
| Celecoxib | 15 | $1,119 | $75 |
| Prednisone | 79 | $845 | $11 |
| Colchicine | 12 | $675 | $56 |
| Alendronate | 19 | $310 | $16 |
| Duloxetine | 12 | $236 | $20 |
| Tramadol | 24 | $230 | $10 |
| Meloxicam | 23 | $186 | $8 |
| Escitalopram | 13 | $130 | $10 |
| Folic Acid | 11 | $41 | $4 |
2022: 6 drugs
| Humira(Cf) | 11 | $86,910 | $7,901 |
| Methotrexate | 92 | $3,530 | $38 |
| Hydroxychloroquine Sulfate | 18 | $2,792 | $155 |
| Leflunomide | 13 | $1,427 | $110 |
| Prednisone | 47 | $502 | $11 |
| Folic Acid | 12 | $49 | $4 |
2021: 5 drugs
| Methotrexate | 61 | $3,910 | $64 |
| Prednisone | 46 | $606 | $13 |
| Diclofenac | 14 | $242 | $17 |
| Alendronate | 15 | $148 | $10 |
| Meloxicam | 15 | $96 | $6 |
2020: 8 drugs
| Methotrexate | 101 | $4,813 | $48 |
| Prednisone | 175 | $3,165 | $18 |
| Hydroxychloroquine Sulfate | 29 | $2,488 | $86 |
| Allopurinol | 46 | $754 | $16 |
| Celecoxib | 14 | $670 | $48 |
| Meloxicam | 20 | $168 | $8 |
| Isoniazid | 12 | $116 | $10 |
| Alendronate | 14 | $97 | $7 |
2019: 16 drugs
| Enbrel Sureclick | 41 | $175,047 | $4,269 |
| Xeljanz | 67 | $150,254 | $2,243 |
| Enbrel | 32 | $136,614 | $4,269 |
| Rasuvo | 66 | $47,745 | $723 |
| Colchicine | 63 | $19,976 | $317 |
| Leflunomide | 96 | $12,507 | $130 |
| Hydroxychloroquine Sulfate | 92 | $10,920 | $119 |
| Uloric | 12 | $8,983 | $749 |
| Prednisone | 253 | $5,169 | $20 |
| Methotrexate | 143 | $3,847 | $27 |
| Allopurinol | 59 | $1,472 | $25 |
| Azathioprine | 19 | $1,159 | $61 |
| Diclofenac | 14 | $944 | $67 |
| Celecoxib | 13 | $612 | $47 |
| Alendronate | 28 | $314 | $11 |
| Meloxicam | 18 | $125 | $7 |
2018: 16 drugs
| Enbrel | 30 | $129,764 | $4,325 |
| Xeljanz | 36 | $124,102 | $3,447 |
| Enbrel Sureclick | 24 | $104,328 | $4,347 |
| Rasuvo | 70 | $45,662 | $652 |
| Xeljanz Xr | 13 | $44,233 | $3,403 |
| Leflunomide | 63 | $20,466 | $325 |
| Colchicine | 47 | $17,884 | $381 |
| Uloric | 14 | $12,864 | $919 |
| Hydroxychloroquine Sulfate | 105 | $6,721 | $64 |
| Methotrexate | 125 | $6,626 | $53 |
| Prednisone | 230 | $5,113 | $22 |
| Azathioprine | 23 | $1,449 | $63 |
| Diclofenac | 20 | $1,429 | $71 |
| Allopurinol | 49 | $1,427 | $29 |
| Celecoxib | 11 | $696 | $63 |
| Meloxicam | 13 | $104 | $8 |
2017: 12 drugs
| Enbrel | 24 | $95,031 | $3,960 |
| Cosentyx Pen (2 Pens) | 12 | $35,710 | $2,976 |
| Leflunomide | 39 | $14,989 | $384 |
| Rasuvo | 28 | $13,827 | $494 |
| Colchicine | 50 | $10,233 | $205 |
| Hydroxychloroquine Sulfate | 41 | $4,747 | $116 |
| Methotrexate | 100 | $4,479 | $45 |
| Prednisone | 137 | $2,782 | $20 |
| Diclofenac | 22 | $1,495 | $68 |
| Allopurinol | 31 | $995 | $32 |
| Sulfasalazine | 12 | $800 | $67 |
| Celecoxib | 15 | $627 | $42 |
2016: 4 drugs
| Hydroxychloroquine Sulfate | 20 | $5,145 | $257 |
| Methotrexate | 74 | $3,289 | $44 |
| Prednisone | 85 | $966 | $11 |
| Sulfasalazine | 12 | $213 | $18 |
2015: 1 drug
| Prednisone | 23 | $227 | $10 |
Money from drug and device companies
$690 in 2025
| 2025 | 10 | 28 | None | $690 |
| 2024 | 8 | 28 | None | $695 |
| 2023 | 4 | 9 | None | $259 |
| 2022 | 2 | 4 | None | $172 |
| 2021 | 6 | 25 | None | $552 |
| 2020 | 8 | 46 | None | $1,556 |
| 2019 | 5 | 9 | None | $348 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| ANI Pharmaceuticals | Purified Cortrophin Gel | $145 | 6 payments
|
| Amgen | Krystexxa | $141 | 6 payments
|
| Janssen Biotech | Tremfya | $109 | 5 payments
|
| Octapharma USA | Octagam Immune Globulin (Human) | $75 | 2 payments
|
| GlaxoSmithKline | Benlysta | $63 | 3 payments
|
| Abbvie | Vraylar | $54 | 2 payments
|
See all 28 published payments
| Janssen Biotech | Meals · 2025-11-12 | Tremfya | $26 |
| GlaxoSmithKline | Meals · 2025-11-10 | Benlysta | $16 |
| Janssen Biotech | Meals · 2025-10-24 | Tremfya | $23 |
| Amgen | Meals · 2025-09-26 | Krystexxa | $22 |
| Janssen Biotech | Meals · 2025-09-17 | Tremfya | $26 |
| ANI Pharmaceuticals | Meals · 2025-09-17 | Purified Cortrophin Gel | $7 |
| Abbvie | Meals · 2025-09-09 | Skyrizi | $25 |
| Amgen | Meals · 2025-08-27 | Krystexxa | $13 |
| ANI Pharmaceuticals | Meals · 2025-06-27 | Purified Cortrophin Gel | $30 |
| GlaxoSmithKline | Meals · 2025-06-25 | Benlysta | $21 |
| Amgen | Meals · 2025-05-30 | Krystexxa | $20 |
| Ucb | Meals · 2025-05-28 | Bimzelx | $31 |
| Amgen | Meals · 2025-05-16 | Otezla | $33 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-14 | Saphnelo | $26 |
| Novartis Pharmaceuticals | Meals · 2025-05-09 | Cosentyx | $21 |
| ANI Pharmaceuticals | Meals · 2025-04-30 | Purified Cortrophin Gel | $29 |
| Amgen | Meals · 2025-04-25 | Krystexxa | $30 |
| Octapharma USA | Meals · 2025-04-18 | Octagam Immune Globulin (Human) | $41 |
| ANI Pharmaceuticals | Meals · 2025-04-17 | Purified Cortrophin Gel | $28 |
| GlaxoSmithKline | Meals · 2025-04-09 | Benlysta | $27 |
| Radius Health | Meals · 2025-03-26 | Tymlos | $26 |
| Janssen Biotech | Meals · 2025-03-19 | Tremfya | $18 |
| Abbvie | Meals · 2025-03-15 | Vraylar | $30 |
| ANI Pharmaceuticals | Meals · 2025-03-12 | Purified Cortrophin Gel | $26 |
| Amgen | Meals · 2025-02-19 | Krystexxa | $23 |
| ANI Pharmaceuticals | Meals · 2025-02-07 | Purified Cortrophin Gel | $25 |
| Octapharma USA | Meals · 2025-01-24 | Octagam Immune Globulin (Human) | $34 |
| Janssen Biotech | Meals · 2025-01-22 | Tremfya | $16 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $695
| Janssen Biotech | Tremfya | $434 | 18 payments
|
| Novartis Pharmaceuticals | Cosentyx | $74 | 3 payments
|
| Amgen | Krystexxa | $57 | 2 payments
|
| Kiniksa Pharmaceuticals International plc | Arcalyst | $35 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Saphnelo | $24 | 1 payment
|
| Otsuka America Pharmaceutical | Rexulti | $24 | 1 payment
|
| Exact Sciences | Cologuard Collection Kit | $23 | 1 payment
|
| GlaxoSmithKline | Benlysta | $22 | 1 payment
|
2023: $259
| Janssen Biotech | Tremfya | $157 | 5 payments
|
| Merck Sharp & Dohme | Belsomra | $52 | 2 payments
|
| Amgen | Otezla | $25 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $23 | 1 payment
|
2022: $172
| Amgen | Evenity | $112 | 3 payments
|
| Radius Health | Tymlos | $59 | 1 payment
|
2021: $552
| Amgen | Evenity | $177 | 4 payments
|
| AbbVie | Rinvoq | $153 | 10 payments
|
| Janssen Biotech | Remicade | $121 | 5 payments
|
| E.R. Squibb & Sons L.L.C. | Orencia | $72 | 4 payments
|
| Horizon Therapeutics plc | Krystexxa | $16 | 1 payment
|
| GlaxoSmithKline | Benlysta | $13 | 1 payment
|
2020: $1,556
| Amgen | Otezla | $424 | 7 payments
|
| Janssen Biotech | Remicade | $351 | 18 payments
|
| AbbVie | Rinvoq | $228 | 7 payments
|
| Janssen Scientific Affairs | Stelara | $214 | 3 payments
|
| GlaxoSmithKline | Benlysta | $129 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Ofev | $119 | 4 payments
|
| Mallinckrodt Hospital Products | Acthar | $72 | 4 payments
|
| Ucb | Cimzia | $19 | 1 payment
|
2019: $348
| Janssen Biotech | Simponi Aria | $135 | 2 payments
|
| Celgene | Otezla | $120 | 2 payments
|
| Amgen | Evenity | $63 | 3 payments
|
| Gilead Sciences | None | $18 | 1 payment
|
| AbbVie | Rinvoq | $13 | 1 payment
|
Professional record
- NPI
- 1518192632
- Licence
- CA A119821California A119821: Current · expires 2027-07-31
- Group
- Livwell Health LLC · Ukiah Adventist Hospital
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207RR0500X (207RR0500X); Internal medicine (207R00000X)
- Mailing address
- 3790 El Camino Real Pmb 564, Palo Alto, CA, 94306
- NPI first listed
- 2009-05-19
- NPI last updated
- 2026-06-18
- NPI record certified
- 2026-06-18
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 50 E Hamilton Ave Ste 200, Campbell, CA, 95008 · 268 Green Valley Rd, Freedom, CA, 95019 · 3790 El Camino Real, Palo Alto, CA, 94306